| Trial | Updated / Type |
Status | Phase | Were Results Reported |
Reported Actual Enrollment |
(MeSH) Terms |
Why Stopped
Limitations And Caveats |
Annotator decisions |
|---|---|---|---|---|---|---|---|---|
| NCT00687674 Details | 2019-08-20 Interventional | 1 | 13 | Dexamethasone Lenalidomide Sorafenib Multiple Myelom… Neoplasms, Plas… Plasmacytoma Multiple Myelom… | Due to study design (and toxicity), this trial closed to accrual prior to opening the phase II
portion. - | |||
| NCT00397878 Details | 2019-08-20 Interventional | 2 | 10 | Saracatinib Adenocarcinoma Colonic Neoplas… Rectal Neoplasm… Recurrence Adenocarcinoma … Adenocarcinoma … Recurrent Colon… Recurrent Recta… Stage IV Colon … Stage IV Rectal… | The study was terminated after all enrolled participants progressed. - | |||
| NCT03879278 Details | 2019-08-19 Interventional | 1 | 8 | Immunoglobulin … Immunoglobulins Amyloidosis | Mild infusion reactions were observed in two healthy volunteers. - | |||
| NCT03242434 Details | 2019-08-19 Interventional | 1 | 18 | Lactulose Mannitol Burns | This trial was supporting the development of an asset which was terminated, thus the data from
the study were no longer required. - | |||
| NCT01124227 2009-017711-15 Details | 2019-08-16 Interventional | 3 | 26 | Icodextrin Heart Failure Congestive Hear… | Due to very specific inclusion criteria the anticipated number of patients was not reached.
Inclusion stopped at N=26, allowing for analyzing primary outcomes. - | |||
| NCT00729807 Details | 2019-08-16 Interventional | 2 | 6 | Pentamidine Melanoma Melanoma (Skin) | Study was closed at the suggestion of DSMB prior to obtaining target enrollment Unable to reach the target number of participants needed before study was closed at the suggestion of DSMB | |||
| NCT02686710 Details | 2019-08-15 Interventional | 4 | 10 | Propofol Sevoflurane Glycogen Syntha… | - - | |||
| NCT02636803 Details | 2019-08-15 Interventional | 2 | 0 | Albendazole Oxfendazole Helminthiasis Trichuriasis | not going to be conducted - | |||
| NCT02394418 Details | 2019-08-15 Interventional | 4 | 0 | Dexmedetomidine Propofol Sevoflurane Delirium Neuroinflammato… | for technical reasons - | |||
| NCT03480867 Details | 2019-08-14 Interventional | 1 | 0 | Temozolomide Glioblastoma Glioblastoma Mu… | competing study was opened by the surgeon after this trial was opened - | |||
| NCT03431675 Details | 2019-08-14 Interventional | 4 | 0 | Ciprofloxacin Meningitis Meningitis, Men… | No epidemic of Men C in 2019 - | |||
| NCT02949492 Details | 2019-08-14 Interventional | 4 | 6 | Interleukin-2 Liver Diseases Transplantation | Safety concerns - | |||
| NCT02337478 Details | 2019-08-14 Interventional | 2 | 5 | Vincristine Leukemia Leukemia, Myelo… Leukemia, Myelo… Recurrent Adult… | The study was stopped early due to futility. - | |||
| NCT02322281 Details | 2019-08-14 Interventional | 3 | 149 | Docetaxel Gemcitabine Paclitaxel Pemetrexed Carcinoma, Non-… Lung Neoplasms Non-small Cell … | Sponsor discontinued development of CO-1686 for NSCLC Due to early study termination, only 149 of 600 planned patients were randomized. | |||
| NCT02200354 Details | 2019-08-14 Interventional | 2 | 20 | Bevacizumab Pemetrexed Carcinoma, Non-… Lung Neoplasms Advanced Non-sm… | inclusion speed - | |||
| NCT01659021 2012-001236-65 Details | 2019-08-14 Interventional | 3 | [6 Refs] | 261 | Idelalisib Ofatumumab Leukemia Leukemia, Lymph… Leukemia, Lymph… Chronic Lymphoc… | - - | ||
| NCT01349673 Details | 2019-08-14 Interventional | 3 | 114 | Budesonide Proctitis Proctocolitis Ulcer Proctosigmoidit… | Terminated for non-safety reasons when Sponsor felt that sufficient long-term safety data was
obtained. - | |||
| NCT02338973 Details | 2019-08-13 Interventional | 1/2 | 4 | Interferon-gamm… Interferons Cone Dystrophy Cone-Rod Dystro… Macular Edema Retinal Degener… Inherited Ophth… Inherited Retin… | - - | |||
| NCT02012192 2013-003868-31 Details | 2019-08-13 Interventional | 1/2 | 133 | Paclitaxel Carcinoma, Ovar… Fallopian Tube … Ovarian Neoplas… Epithelial Ovar… Fallopian Tube … Primary Periton… | production of IMP has stopped - | |||
| NCT03547154 Details | 2019-08-12 Interventional | 2/3 | 344 | Interferon alph… Interferon-alph… Interferons Peginterferon a… Leukemia Leukemia, Myelo… Leukemia, Myelo… Chronic Myeloge… | - AE Preferred Terms were converted from WHO-ART dictionary to the MedDRA version 10.0 |